The PSA test has been the gold-standard treatment for detecting prostate cancer, but key shortcomings have prevented national screening programmes.

What is the outlook of the Stellantis share price after forming a bearish flag pattern? We explain what to expect in the near ...

The use of serum prostate-specific antigen (PSA) levels to screen for prostate cancer is controversial because of the difficulty in differentiating clinically insignificant cancers from those that ...

The Vaal Dam’s water levels have taken another hit, dropping by 2% over the past week. This comes as the Minister of Water and Sanitation Pemmy Majodina and the Gauteng Premier Panyaza Lesufi ...

PSMA PET imaging shows a 35% positivity rate in prostate cancer patients with PSA levels below 0.5 ng/mL post-radical prostatectomy. Factors linked to suspicious PSMA activity include prior ...

You’ve reached your account maximum for followed topics. WhatsApp beta version 2.24.24.5 faces an issue wherein the app returns to a green screen while opening a ...

BTC/USD chart with trend lines. Source: Checkmate/X Levels to watch include “classic” bull market support components such as the 200-day simple moving average (SMA) and short-term holder cost ...

It’s normal to have a small amount of PSA in your blood, and as you get older and your prostate gets bigger, the levels rise slightly. However, a raised PSA level may suggest you have a problem with ...

PSA is not diagnostic. A raised PSA level does not necessarily mean there is cancer. It can be elevated with other conditions too, such as inflammation. If you ask for a PSA test, your doctor may ...

By picking up conditions at the earliest stages there is the best chance of treatment or taking steps to avoid getting ill says Dr Donald Grant, senior clinical advisor to The Independent Pharmacy.

Bloom is operating at a loss because it is operating below its breakeven level. This is illustrated in Chart 4. I estimated that to break even in 2023, its revenue would have to be 22% larger.